Biostar Pharmaceuticals (BSPM) Q4 EPS Drops to $0.03; Revs Lighten

Biostar Pharmaceuticals (NASDAQ: BSPM) reported Q4 EPS of $0.03, versus $0.22 reported last year. Revenue for the quarter came in at $25.99 million, versus $28.28 million reported last year.

For earnings history and earnings-related data on Biostar Pharmaceuticals (BSPM) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c
• Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
• Tvardi Therapeutics (TVRD) Tops Q2 EPS by 1c